# Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment

> **NCT00105417** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 20 (—)

## Conditions studied

- HIV Infections
- HIV

## Interventions

- **DRUG:** IL-7

## Key facts

- **NCT ID:** NCT00105417
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 20 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00105417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00105417, "Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00105417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*